Lipigon Pharmaceuticals AB
LPGO | ST
Overview
Corporate Details
- ISIN(s):
- SE0015382072
- LEI:
- 549300XPO40YR12SLY87
- Country:
- Sweden
- Address:
- Tvistevägen 48 C, 907 36 Umeå
- Website:
- https://lipigon.se/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Lipigon Pharmaceuticals AB is a clinical-stage biopharmaceutical company that develops novel therapeutics for diseases caused by lipid-related disorders. The company's operations are founded on over 50 years of lipid biology research from Umeå University. Its pipeline is led by the RNA-based drug candidate Lipisense®, designed to lower triglycerides, which is advancing into Phase II clinical studies. Other pipeline projects include an RNA therapeutic for lung injury and a small-molecule drug for dyslipidemia. Lipigon strategically focuses on rare diseases and genetically defined patient segments to de-risk and accelerate clinical development, with the goal of becoming a key partner for major pharmaceutical companies in its field.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Lipigon Pharmaceuticals AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Lipigon Pharmaceuticals AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Lipigon Pharmaceuticals AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-16 | Johan Living | Other | Buy | 260,000 | 51,688.00 SEK |
